Niagara Falls
THE
NIAGARA FALLS REPORTER
LOCAL NEWS  •  LOCAL VOICES  •  LOCAL MATTERS

Crucial Drug Discount Program at Risk

R
Reporter · September 22, 2016
Crucial Drug Discount Program at Risk
SharefXin✉


By Joseph A. Ruffolo, President & CEO

Niagara Falls Memorial Medical Center

 

Niagara Falls Memorial Medical Center is a safety-net facility. That means we treat all sick people regardless of their ability to pay. Many of our patients are on Medicaid, Medicare or lack health insurance altogether. A little-known federal statute called the 340B drug discount program helps us care for the neediest in our community.

Signed into law by President George H.W. Bush in 1992, the program requires drug companies to sell discounted medications to healthcare providers that serve high numbers of low-income Medicare and Medicaid patients or are located in remote rural areas. These safety-net hospitals pass the discounts on to needy patients and also use savings from the program to fund cancer, HIV/AIDS, diabetes and primary care clinics that help the underserved.

ruffolo2-1024x682
Niagara Falls Memorial Medical Center CEO Joseph Ruffolo writes about 340b discount drug plan.

Unfortunately, this critically important program is at risk. In recent years, pharmaceutical manufacturers have become less willing to share their profits to help those in need, and now they want to scale back the 340B program in Washington by limiting hospital and patient eligibility. They’ve taken this position even though 340B drugs amount to just 2 percent of the $457 billion annual U.S. pharmaceutical market.

Niagara Falls Memorial Medical Center will save approximately $400,000 this year thanks to the program. In order to serve all who walk in our door, we provide $2 million per year in charity and uncompensated care. The program has also helped us fund the Wellness Connection Center behavioral health program and offsets the cost of our dedicated psychiatric emergency department.

 hqdefault

Treating patients with limited or no financial means is enormously expensive. Hospitals in the 340B program serve nearly twice as many needy patients as other providers. They also supply nearly 60 percent of all uncompensated care.

It’s important to understand that 340B is not taxpayer funded – instead it requires very profitable drug companies to give a discount to health care providers that serve our most vulnerable citizens. Simply put, these companies can afford to help. If the program were significantly reduced or eliminated, Niagara Falls Memorial Medical Center would be forced to cut back drug access and clinical care to the needy.

Our community deserves better. Please reach out to your local member of Congress and U.S. senator today to express the need for the continuation of the 340B program.

SharefXin✉

Comments (0)

Leave a comment

More From Niagara Falls Reporter

Dr. Bob's Sixth Step: Protect Your Sleep With a Red Light
Investigative

Dr. Bob's Sixth Step: Protect Your Sleep With a Red Light

By Dr. Robert Lee Oksenholt · October 10, 2026

Dr. Bob's sixth step for aging stronger after 60 is protected sleep: a consistent bedtime, screens down before bed, and dim red night lights that won't suppress melatonin. The motion-activated lights also light the path to the bathroom, helping prevent the falls that put older adults at risk of hip fractures.

Dr. Bob's Five-Part Plan to Age Stronger After 60
Investigative

Dr. Bob's Five-Part Plan to Age Stronger After 60

By Guest View · October 8, 2026

Dr. Robert Lee Oksenholt outlines five essentials for staying strong after 60: walking, lifting weights, creatine, high-polyphenol olive oil, and a daily multivitamin. Walking and lifting do the most for heart, brain, muscle, and bone health, while the supplements offer affordable support.

Cornell 7 Accuser's Sworn Statement Contradicts Her Lawsuit
Investigative

Cornell 7 Accuser's Sworn Statement Contradicts Her Lawsuit

By Frank Parlato · October 4, 2026

Gov. Kathy Hochul appointed Attorney General Letitia James as special prosecutor in the Cornell 7 case, which involves allegations that seven men drugged and sexually assaulted a Cornell student at the Chi Phi fraternity in October 2024. The men deny the allegations, and the accuser's sworn statement to police differs